Belgium· BE-AMP-SAM302732-00
Geltim 1 mg/g
A timolol product containing timolol maleate, registered in Belgium by Laboratoires Théa. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Timolol is registered in 14 of 19 countries.
Countries holding a registration under ATC S01ED01 (timolol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Timolol · ATC S01ED01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of timolol costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Timolol · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- IT Italy$2.87
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Timolol Maleate
- Manufacturer
- Laboratoires Théa
- Country
- Belgium (BE)
- ATC code
- S01ED01
- ATC class
- Timolol
- Defined daily dose
- 0.2 g, AS
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
1 priced- be_apb2529618EUR 21.83
- be_apb0792218
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
144 interactions on record for timolol.
Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Timolol · interactions on record
144 records
- 28 severe
- 114 moderate
- 2 minor
Most severe, free to view
- EpinephrineB02BC09severe
- EpinephrineC01CA24severe
- OrciprenalinC01CA29severe
- TheophyllinC01EB28severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Timolol in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- ItalyGENISIASIFI S.P.A.
- NetherlandsGelisia 1 mg/g, ooggel in verpakking voor éénmalig gebruikSIFI SpA
- FinlandTimosanSanten Oy
- FranceGELTIM LP 1 mg/g, gel ophtalmique en récipient unidoseDIFARMED (ESPAGNE)
- SpainGELISIA 1 MG/G GEL OFTALMICOSifi S.P.A.
- IcelandTimosan DepotSanten Oy*
- IrelandTimofluid 1 mg/g eye gel in single-dose containerLaboratoires Thea
- United KingdomBetim 10mg tabletsMeda Pharmaceuticals Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Timoftal, Timolol Micro Labs
- Bulgaria · Гелтим, Кузимолол
- Cyprus · Lithimole
- Czechia · Oftan, Timo-Comod
- Germany · Dispatim, Gelisia
- Denmark · Eyopto, Optimol
- Estonia · Timosan
- Spain · Cusimolol, Gelisia
- Finland · Oftan Timolol, Timosan
- France · Geltim Lp, Genoptol
- United Kingdom (Northern Ireland) · Eysano, Timolol Blumont Pharma
- Greece · Geltim, Lithimole
- Croatia · Timalen
- Hungary · Cusimolol
- Ireland · Timofluid, Timolol Brown & Burk Ir
- Iceland · Timosan Depot
- Italy · Blocadren, Cusimolol
- Lithuania · Oftan, Timosan
- Luxembourg · Dispatim, Geltim
- Latvia · Oftan Timolol, Timosan
- Malta · Lithimole
- Netherlands · Gelisia, Timo-Comod
- Norway · Oftan, Timosan
- Poland · Cusimolol, Timo-Comod 0,5 %
- Portugal · Dibetop, Timabak
- Romania · Gelisia, Geltim
- Sweden · Optimol, Timosan
- Slovenia · Timalen, Timoptic -Xe
- Slovakia · Unitimolol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1de2d40-4d42-4ab4-8e7a-d30ad870244c GET /v1/drugs/e1de2d40-4d42-4ab4-8e7a-d30ad870244c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Eye gel",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Geltim 1 mg/g",
"name_fr": "Geltim 1 mg/g",
"name_nl": "Geltim 1 mg/g",
"amp_code": "SAM302732-00",
"strengths": [
"1.3700",
"1.0000",
"0.2000",
"45.0000"
],
"pack_count": 2,
"substances": [
"Timolol Maleate",
"Timolol",
"Sodium Acetate Trihydrate",
"Sorbitol Liquid"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Timolol",
"authorisation_numbers": [
"BE302732"
]
}See everything about timolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.